DE69712057T2 - Neue vorrichtungen zur transdermalen verabreichung von trimegestone - Google Patents

Neue vorrichtungen zur transdermalen verabreichung von trimegestone

Info

Publication number
DE69712057T2
DE69712057T2 DE69712057T DE69712057T DE69712057T2 DE 69712057 T2 DE69712057 T2 DE 69712057T2 DE 69712057 T DE69712057 T DE 69712057T DE 69712057 T DE69712057 T DE 69712057T DE 69712057 T2 DE69712057 T2 DE 69712057T2
Authority
DE
Germany
Prior art keywords
trimegestone
transdermal administration
new devices
new
devices
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69712057T
Other languages
English (en)
Other versions
DE69712057D1 (de
Inventor
Jean-Luc Dubois
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Application granted granted Critical
Publication of DE69712057D1 publication Critical patent/DE69712057D1/de
Publication of DE69712057T2 publication Critical patent/DE69712057T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
DE69712057T 1996-06-11 1997-06-10 Neue vorrichtungen zur transdermalen verabreichung von trimegestone Expired - Fee Related DE69712057T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9607208A FR2749586B1 (fr) 1996-06-11 1996-06-11 Nouveaux dispositifs destines a l'administration transdermique de la trimegestone, leur procede de preparation et leur application a titre de medicaments
PCT/FR1997/001023 WO1997047333A1 (fr) 1996-06-11 1997-06-10 Nouveaux dispositifs destines a l'administration transdermique de la trimegestone

Publications (2)

Publication Number Publication Date
DE69712057D1 DE69712057D1 (de) 2002-05-23
DE69712057T2 true DE69712057T2 (de) 2002-10-02

Family

ID=9492919

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69712057T Expired - Fee Related DE69712057T2 (de) 1996-06-11 1997-06-10 Neue vorrichtungen zur transdermalen verabreichung von trimegestone

Country Status (23)

Country Link
EP (1) EP0906127B1 (de)
JP (1) JP2000514416A (de)
CN (1) CN1110327C (de)
AR (1) AR013580A1 (de)
AT (1) ATE216269T1 (de)
AU (1) AU717335B2 (de)
BR (1) BR9709690A (de)
CA (1) CA2257902A1 (de)
CZ (1) CZ295227B6 (de)
DE (1) DE69712057T2 (de)
DK (1) DK0906127T3 (de)
ES (1) ES2173453T3 (de)
FR (1) FR2749586B1 (de)
HU (1) HU225034B1 (de)
IL (1) IL127281A0 (de)
NO (1) NO315149B1 (de)
PL (1) PL189533B1 (de)
PT (1) PT906127E (de)
RU (1) RU2204417C2 (de)
TR (1) TR199802578T2 (de)
TW (1) TW474826B (de)
WO (1) WO1997047333A1 (de)
ZA (1) ZA975168B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2782635B1 (fr) * 1998-08-27 2001-09-14 Oreal Dispositif aerosol contenant un polycondensat comprenant au moins un motif polyurethanne et/ou polyuree
ITMI20020798A1 (it) * 2002-04-15 2003-10-15 F T Holding S A Cerotti transdermici a matrice adesiva siliconica stabilizzati con copolimeri metacrilici
UA84303C2 (ru) * 2003-10-28 2008-10-10 Новен Фармасьютикалз, Инк. Система для трансдермальной доставки лечебного средства
AP2006003648A0 (en) * 2003-12-05 2006-06-30 Namibia Medical Invest Pty Ltd Patch
JP2006230930A (ja) * 2005-02-28 2006-09-07 Alcare Co Ltd 貼付材
CA2548864C (en) 2005-06-06 2012-12-11 Nitto Denko Corporation Percutaneous absorption-type pharmaceutical preparation
US7879942B2 (en) 2006-10-05 2011-02-01 Eastman Chemical Company Switchable adhesive article for attachment to skin and method of using the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2430953A1 (fr) * 1978-07-13 1980-02-08 Roussel Uclaf Nouveaux derives 3,20-dioxo 4,9-diene 21-hydroxyle, leur procede de preparation et leur application comme medicaments
US4883669A (en) * 1985-02-25 1989-11-28 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for estradiol and other estrogenic steroids and process for administration
AU601528B2 (en) * 1986-12-22 1990-09-13 Ortho-Mcneil Pharmaceutical, Inc. Resilient transdermal drug-delivery device and compositions and devices employing fatty acid esters/ethers of alkanediols and percutaneous absorption enhancers
US5186939A (en) * 1987-04-23 1993-02-16 Cygnus Therapeutic Systems Laminated composite for transdermal administration of fentanyl
US4906475A (en) * 1988-02-16 1990-03-06 Paco Pharmaceutical Services Estradiol transdermal delivery system
DE4309830C1 (de) * 1993-03-26 1994-05-05 Lohmann Therapie Syst Lts Wirkstoffpflaster für die Abgabe von Estradiol an die Haut
DE4405899A1 (de) * 1994-02-18 1995-08-24 Schering Ag Mittel zur transdermalen Applikation enthaltend Desogestrel

Also Published As

Publication number Publication date
RU2204417C2 (ru) 2003-05-20
WO1997047333A1 (fr) 1997-12-18
PL189533B1 (pl) 2005-08-31
NO985791D0 (no) 1998-12-10
BR9709690A (pt) 1999-08-10
ZA975168B (en) 1998-07-22
CZ295227B6 (cs) 2005-06-15
FR2749586A1 (fr) 1997-12-12
ATE216269T1 (de) 2002-05-15
PT906127E (pt) 2002-09-30
CZ410798A3 (cs) 1999-09-15
AR013580A1 (es) 2001-01-10
NO985791L (no) 1999-02-11
ES2173453T3 (es) 2002-10-16
CA2257902A1 (fr) 1997-12-18
DE69712057D1 (de) 2002-05-23
DK0906127T3 (da) 2002-08-05
AU717335B2 (en) 2000-03-23
EP0906127A1 (de) 1999-04-07
CN1110327C (zh) 2003-06-04
EP0906127B1 (de) 2002-04-17
AU3266097A (en) 1998-01-07
FR2749586B1 (fr) 1998-08-07
NO315149B1 (no) 2003-07-21
TR199802578T2 (xx) 1999-03-22
HUP9903340A3 (en) 2000-04-28
JP2000514416A (ja) 2000-10-31
PL330535A1 (en) 1999-05-24
HU225034B1 (en) 2006-05-29
TW474826B (en) 2002-02-01
CN1227503A (zh) 1999-09-01
HUP9903340A2 (hu) 2000-03-28
IL127281A0 (en) 1999-09-22

Similar Documents

Publication Publication Date Title
DE69713989D1 (de) Fentanyl enthaltendes transdermal-pflaster
DE69530004D1 (de) Transdermale verabreichung von apomorphin
ATE253361T1 (de) Mittel zur gesteuerten freisetzung von paroxetin
DE69628448D1 (de) Transdermale verabreichungsform von flurbiprofen
ID17499A (id) Alat suntik
DE69532188D1 (de) Flüssigkeit zur Beschichtung von Zähnen
DE59500266D1 (de) Transdermales therapeutisches System zur Applikation von Naloxon
DE69522349T2 (de) Von der Haut leicht abnehmbares Pflaster zur transdermalen Anwendung
ATE216269T1 (de) Neue vorrichtungen zur transdermalen verabreichung von trimegestone
DE69720600D1 (de) Mittel zur Verhinderung von schlechten Gerüchen
DE69834937D1 (de) Antibiotika zur behandlung von magengeschwuren
DE59709922D1 (de) Pflaster zur transdermalen anwendung von pergolid
DE69821096D1 (de) Pflaster-zubereitungen zur transdermalen absorption
DE69515179D1 (de) Bauelement zur errichtung von strukturen
DE69412178D1 (de) Apparat zur Behandlung von Lagen
DE69832974D1 (de) Gerät zur intrakardialen verabreichung von medikamenten
ATE235494T1 (de) Imino-aza-anthracyclonderivate zur behandlung von amyloidosis
DE69806062T2 (de) Kombinationstherapie zur behandlung von aids
DE9409784U1 (de) Vorrichtung zur transdermalen Applikation von Wirkstoffen
DE69333009T2 (de) Transdermale verabreichung von ketorolac
DE29700578U1 (de) Pflaster zur transdermalen Applikation von Wirkstoffen
DE29521125U1 (de) Gerät zur Applikation von Akupunkturnadeln
ATE284706T1 (de) Neue verbesserte formulierung zur behandlung von thromboembolismus
DE29721350U1 (de) Stoff zur Heilbehandlung
DE29808325U1 (de) Gerät zur Farbbestimmung von Zähnen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC

8339 Ceased/non-payment of the annual fee